MiR-486-5p Serves as a Good Biomarker in Nonsmall Cell Lung Cancer and Suppresses Cell Growth With the Involvement of a Target PIK3R1
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-486-5p Serves as a Good Biomarker in Nonsmall Cell Lung Cancer and Suppresses Cell Growth With the Involvement of a Target PIK3R1
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-26
DOI
10.3389/fgene.2019.00688
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer
- (2018) Zhao-jia Gao et al. PATHOLOGY RESEARCH AND PRACTICE
- miR-486-5p regulates the migration and invasion of colorectal cancer cells through targeting PIK3R1
- (2018) Yuhao Zhang et al. Oncology Letters
- Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
- (2018) Ádám Nagy et al. Scientific Reports
- Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection
- (2017) Maria Sromek et al. CELLULAR ONCOLOGY
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer
- (2016) Fei Tian et al. GENE
- miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma
- (2016) Haifeng Lian et al. OncoTargets and Therapy
- miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial–mesenchymal transition
- (2016) Xiaoguang Zhang et al. OncoTargets and Therapy
- Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
- (2016) H. Zhang et al. Cancer Discovery
- PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer
- (2015) LI-XU YAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells
- (2015) Genevieve L. Weber et al. Oncotarget
- MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1
- (2014) Xin-Ping Huang et al. FEBS Journal
- Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer
- (2014) Wenshuai Pang et al. Molecular Cancer
- PIK3R1 underexpression is an independent prognostic marker in breast cancer
- (2013) Magdalena Cizkova et al. BMC CANCER
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
- (2013) J Wang et al. ONCOGENE
- Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer
- (2013) Y. Peng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Correction: The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
- (2012) Cancer Discovery
- Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking
- (2011) Paul Mellor et al. BIOCHEMICAL JOURNAL
- PIK3R1 (p85 ) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
- (2011) M. E. Urick et al. CANCER RESEARCH
- A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
- (2011) X. Tan et al. CLINICAL CANCER RESEARCH
- Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer
- (2011) H.-K. Oh et al. CLINICAL CANCER RESEARCH
- The Phosphoinositide 3-Kinase Regulatory Subunit p85 Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling
- (2010) C. M. Taniguchi et al. CANCER RESEARCH
- Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
- (2010) Lei Yu et al. INTERNATIONAL JOURNAL OF CANCER
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data
- (2010) Jian-Hua Yang et al. NUCLEIC ACIDS RESEARCH
- Small non-coding RNAs in animal development
- (2008) Giovanni Stefani et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
- Suppression of non-small cell lung tumor development by the let-7 microRNA family
- (2008) M. S. Kumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started